cxcr4

Documents about cxcr4

• Expression of CXCR4 in Patients With Systemic Lupus Erythematosus#898617ClinicalTrials.gov
• Antigenically Distinct Conformations of CXCR4#68197HAL (France)
• CCR7 and CXCR4 expression in primary head and neck squamous cell carcinomas and nodal metastases–a clinical and immunohistochemical study#208062Zenodo (CERN)
• As Part of a Pilot Study, Visualization of Inflammatory Activity in Systemic Sclerosis Using CXCR4 PET/CT#1044540ClinicalTrials.gov
• Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases#887353ClinicalTrials.gov
• Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins#213127HAL (France)
• Propriétés génotypiques et phénotypiques des glycoprotéines d'enveloppe de VIH-1 utilisant CXCR4 chez les personnes récemment infectées#391897HAL (France)
• Analysis of CXCR4 in microglial pyroptosis after ischemia–reperfusion#988096JLUpub
• Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma#1198222ClinicalTrials.gov
• CD133+ progenitor cells promote pulmonary hypertension through CXCR4 signaling#623296bioRxiv / medRxiv
• Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4(+) neutrophils and S100A8(+) monocytes.#135901NCBI PubMed Central
• Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors#643980IBISS
• Efficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization#1251412HAL (France)
• Autologous CD4 T-Cells in HIV (C34-CXCR4)#1280110ClinicalTrials.gov
• CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma#1056931ClinicalTrials.gov
• CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients#1251465HAL (France)
• Intracellular and nuclear CXCR4 signaling promotes terminal erythroblast differentiation and enucleation#446716PubMed Central
• Identification of the Cytoplasmic Domains of CXCR4 Involved in Jak2 and STAT3 Phosphorylation#68200HAL (France)
• Ligand-regulated ACKR3 nanoclustering shapes CXCR4 signaling at the plasma membrane#445498Europe PMC
• First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4#902317ClinicalTrials.gov
• CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management.#135921NCBI PubMed Central
• CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis#881988ClinicalTrials.gov
• "Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.#1163878ClinicalTrials.gov
• In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET#888014ClinicalTrials.gov
• CXCR4 Inhibition Induces Tumor Necrosis by Selectively Targeting the Proliferating Blood Vessels in Oral Squamous Cell Carcinoma#251456OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Functional proteomics of CXCR4 and ACKR3-operated signaling#1079276HAL (France)
• CD48 and CXCR4 as immune-associated biomarkers in periodontitis: an integrative analysis and validation study.#378466NCBI PubMed Central
• The Role of Cxcr4Hi neutrOPhils in InflueNza#827357ClinicalTrials.gov
• Lymphatic Organs and Myocardium After Myocardial Infarction#865234ClinicalTrials.gov
• TRANSCRIPTIONAL REGULATORY PROGRAM CONTROLLED BY MYB IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA#1159089ScholarBank@NUS
• Symptomatic Improvement in Human Papillomavirus-Induced Epithelial Neoplasia by Specific Targeting of the CXCR4 Chemokine Receptor#1251522HAL (France)
• METTL7A-Dependent m(6)A Methylation Orchestrates CXCR4(hi) Neutrophil Pathogenicity and NETosis in Skin Inflammation.#469135NCBI PubMed Central
• Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy.#222958NCBI PubMed Central
• AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia#1446391ClinicalTrials.gov
• Comprehensive In Silico Analysis of the CXCL12, C55Y Mutation Reveals Structural and Functional Disruption in CXCR4/CXCR7 Signaling.#437016NCBI PubMed Central
• Ilexoside K Ameliorates Atherosclerosis by Suppressing CD72(hi) Macrophages and Blocking CXCL12-CXCR4 Axis to Inhibit Endothelial Pyroptosis.#1107569NCBI PubMed Central
• Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma#1352522ClinicalTrials.gov
• Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers#1408474ClinicalTrials.gov
• Cooperation of the V1/V2 and V3 Domains of Human Immunodeficiency Virus Type 1 gp120 for Interaction with the CXCR4 Receptor#68194HAL (France)
• CD31+ T-cells express greater VEGF-A and CXCR4 levels than CD31- counterparts with VEGF-A expression exacerbated with advancing age#146494bioRxiv / medRxiv
• Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade.#430776NCBI PubMed Central
• Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"#875953ClinicalTrials.gov
• 68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma#1086196ClinicalTrials.gov
• Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potential#1000776HAL (France)
• Neutrophil aging exacerbates high fat diet induced metabolic alterations#1426046IRIS
• Deciphering IFN signaling in gastric cancer: A single-cell and bulk transcriptomic integration reveals CXCR4 as a key immunomodulator and prognostic determinant.#143193NCBI PubMed Central
• Auto-immunity in Lupus Patients After Influenza Vaccine#1385402ClinicalTrials.gov
• PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)#906380ClinicalTrials.gov
• A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome#916063ClinicalTrials.gov
• The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma#1115106ClinicalTrials.gov